Do you incorporate carboplatin into the treatment for triple negative breast cancer?

The GeparSixto, CALGB 40603, and more recently Prospero support doing it; however, it is not currently endorsed by NCCN and the latter Prospero study calls into question its role in BRCA mutated tumors, contradictory to the TnT study results. Based on this information, in which scenario would you consider it?

Answer from: Medical Oncologist at Academic Institution

In the neoadjuvant setting, I recommend the addition of carboplatin in all patients (unless medically contraindicated) with stage IIA or higher TNBC. There are now 3 randomized studies - CALGB 40603, GeparSixto and BrighTNess - that have demonstrated significantly higher pCR rates with carboplatin t...

Comments

Medical Oncologist at Texas Tech University Health Sciences Center
Very helpful, thank you.

Medical Oncologist at Jackson-Madison County General Hospital
Do you still feel the same and incorporate carbopl...

Medical Oncologist at Warren Alpert Medical School of Brown University
Absolutely. There is no doubt that adding carbopla...

Please select the option that best describes you:

Do you incorporate carboplatin into the treatment for triple negative breast cancer?

Related Questions